Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Therapy Cells, Inc. (TCEL)

TCEL RSS Feed
Add TCEL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator ChannelTrader, GreenMachine, pay streak, MIKEY501
Search This Board:
Last Post: 8/22/2014 11:31:59 AM - Followers: 400 - Board type: Free - Posts Today: 26

 



TCEL  Therapy Cells, Inc.






THE  FOLLOWING INFO CAN BE VERIFIED AT :  http://www.otcmarkets.com/stock/TCEL/quote




Market value as of June  06 2014
$719,086



Shares outstanding as of  June 06 2014
359,542,945



Float as of June 06 2014
359,542,945



A/S
500,000,000 a/o Jun 06,2014

Industry Classification:
Medical Labratories, Development stage company

Check here for today's  regSHO standing:  (failed to deliver shares)

http://www.nasdaqtrader.com/trader.aspx?id=RegSHOThreshold


http://otcshortreport.com/index.php?index=TCEL&action=view#.U445LMpOXF8






COMPANY CONTACT INFO:
500 Hazelwood Rd
Venice, Florida
34293
telephone 44 173 246  0224
email :   info@therapycells.com
 

Business Description


What is Cell Therapy?

Discovered by Dr Casey and Dr Fry, the success of Cell Therapy technology lies in its simplicity. Previously it was believed that once mature, cells were no longer capable of dividing. As a result, many specialists have concentrated on stem-cell research (trying to train one type of cell to become another type of cell), for example trying to get a stem-cell to become a tendon cell. In practice this theory hasn’t been completely successful to-date, with previous attempts to heal tendons resulting in the formation of scar tissue.

Moving completely away from stem-cell theory, Dr Casey and Dr Fry’s own theory of “spatial compaction” is the basis for their revolutionary discovery, dubbed Cell Therapy.

Spatial compaction accepts that cells in their natural environment reach a point where they effectively “fill the skin they’re in” and therefore do not have space to divide any further. However, it surmises that if they were removed from their environment and cultured, they could be induced to start dividing again and become ‘therapy cells.’

In simple terms Dr Casey explains, “Mature cells don’t actually stop, they just go on pause because they don’t have space to keep dividing. It’s a bit like a goldfish – put it in a small bowl and it’ll grow into a small fish, put it in a large pond and it’ll continue to grow.”

Focussing only on the adult cell that is dedicated to its role, Cell Therapy technology involves taking a very small sample of the target tissue. The cells are then grown in sterile laboratory conditions with millions of new cells being produced. These new cells are then transplanted back into the damaged area where they effectively rebuild the damaged tissue.
 

Proven Success

So far Cell Therapy has been successfully tested on three horses that have returned to competition with other treated horses waiting in the wings.

If Cell Therapy continues to be as successful as it currently is, the short-term implications are huge for the racing industry. With the ability to bank healthy cells for future restorative use, keeping winning horses in the race for longer will become a realit

 



Therapy Cells has developed a novel and highly efficient method of growing tendon and articular cartilage for auto transplantation into individual, affected patients.  Our company has developed new cell theory that dispenses with the notion that cells can not divide once they are fully mature.  We have shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory.

The need for tissue and organ repair is growing. This is due to the continual growth of our population, coupled with individual needs to maintain good health. And, as our population grows, so does the number of older people seeking to maintain optimal activity levels.


 

The company’s new approach to cell growth has already been applied to the repair of tendons and joints. The technology has also been applied to the re-growth of pancreas and heart tissue. Rejection does not occur as the new cells are from that individual and are recognised by the body as non foreign. It is our belief that this new method of cell growth will be successfully used for cell and organ repair in many parts of the human body.
 


For more information, please contact:

info@therapycells.com
info@kumeu.com

 

 

 

 

Technology

Therapy Cell has developed a methodology that allows adult cells to divide and grow in controlled laboratory conditions.  These new cells can then be used for transplantation back to damaged tissue to enact tissue and organ healing.

To date, the technology has been used for the growth and transplantation of:

  1. Tendons and ligaments
    and
  2. Articular cartilage

We have also applied this technology to successfully grow pancreatic cells, for treatment of diabetes, and cardiac cells for the treatment of heart disease, as well as other cell types from many other tissues.

Therapy Cells has shown that given the right culture conditions, these cell types can be grown into  millions of new cells, and then successfully transplanted back into the injured tissue of the individual who has donated the cells, leading to tissue repair with one's one cells.


 


Cartilage cells grown in vitro

EquineCartilage1.jpgEquineCartilage2.jpgEquineCartilage3.jpgEquineCartilage4.jpg

                                                                                                                    Figure 1                                                 Figure 2                                                           Figure 3                                                         Figure 4
 


The company

Therapy Cells Inc (2011)  will bring this transformation technology for tendon repair  to the human market.
 

Dr. Patrick (Paddy) J Casey, BVSc, PhD, MRCVS

Dr. Casey is a pre eminent scientist who, at the age of 25, headed up his own University research programme based at Australasia’s leading medical college, the Faculty of Medical and Health Sciences, University of Auckland.  He has been founder and director of a number of companies that are successful on the national and international stage. He has a reputation for being a highly original thinker who knows how to achieve full implementation of his projects. Dr. Casey travels extensively around the world where he collaborates and consults with a number of top academic minds in relevant fields. He is also associated with a number of top academic institutions.  His contact with leaders in various fields has lead to major scientific collaborations at his young age.

DSC00804.JPG

more information about him:

http://www.voorjaarsdagen.org/index.php?option=com_content&view=article&id=232:cv-dr-pa


LINK TO A MEDICAL PAPER ON STEM CELL MEDICINE PREPARED IN PART BY DR CASEY: JANUARY 2013:

http://www.jbc.org/content/288/11/7986.abstract



 


 

Mr. Garry Green, BCom

Mr Green left a successful accountancy career to follow his entrepreneurial aspirations.  He has been very successful in a variety of business forums and owns a number of diverse and successful companies.  Garry is a director on boards of leading New Zealand companies, and has been a great organizational asset to Therapy Cell.

 

 

 




http://www.horsetalk.co.nz/news/2012/03/017.shtml#ixzz2rfM3niy8
Reuse: You may use up to 20 words and link back to this page. Other reuse not permitted
Follow us: @HorsetalkNZ on Twitter | Horsetalk on Facebook

 
 

 

 

Revolutionary science restores horse's Olympic hopes

 

March 2, 2012

 

Two years ago, Angelli, a grand prix showjumping horse from Southern California, was facing retirement or, at worst, euthanasia. His career as a contender for the 2012 Olympic Games was in tatters.

 


Harley Brown and Angelli.
Just the previous weekend, he and his international rider and trainer, Harley Brown of Australia, had been unable to compete in a major Californian show, as the previously grand prix level show jumper could not clear even the lowest of jumps.

Then a phone call was made to an internationally recognised veterinarian and scientist who travels the world as a consultant from New Zealand.

Three days later, Dr Patrick Casey arrived with his ultrasound machine and, after examining Angelli, gave Harley the heartbreaking news.

"He's torn his hind tendon badly, sort of shredded it," Casey explained.

Tendon injuries can be career-ending for horses - only 5 to 15 per cent of those with damaged tendons ever make it back to competition.

Casey explained a revolutionary tendon treatment that had already been shown to get 85 per cent of horses with torn tendons back to full competition.

It involves taking about 100 tendon cells from the injured horse without causing any harm to the animal.

Using a patented procedure, 20 to 40 million tendon cells are then grown in an incubator and transplanted back to the site of injury.

Brown and Angelli's owner, Mark Harryman, knew that unless they had a go, all hope was lost for their horse's future jumping career.

The treatment worked. Not only is Angelli's shredded tendon healed, but he has a chance to be selected to jump at the London Olympics for Australia with Harley Brown.

"We just could not have ever imagined how well this science works," Brown said.

"I have never heard of a horse coming back from this injury, let alone being competitive at the highest level. It's just like a dream."

Late in March, Casey, Brown and Harryman will be reunited in Wellington, Florida, where Angelli's American preparation will end and he will fly to Europe for more pre-Olympic trials.

It is fair to say that Dr Casey "wouldn't miss it for the world and, considering where I come from, wouldn't mind a cold one to celebrate."

Last year, Casey set up a public company in the United States called Therapy Cells, Inc.

It holds the exclusive technology that allows adult cells from a specific tissue, such as an Achilles tendon, to grow again from individual cells, to enact repair and regeneration of that tissue, effectively bypassing the need for stem cell treatment.

The company has developed a novel and highly efficient method of growing tendons and articular cartilage for auto transplantation into injured horses or people.

Of real interest to veterinarians worldwide is the clinical success in horses.

Sixty-six horses have been treated with therapy cells to date. The data accumulated from horses will ultimately have direct application in seeking Food and Drug Administration (FDA) approval for human use.

The company's technique dispenses with the traditional notion that cells cannot divide once they are fully mature.

 


Dr Patrick Casey
Casey has shown that adult cells, given the right environment, can be induced to divide in the laboratory. These newly grown cells can then be put back into damaged tissue in the body, to enact tissue and organ healing.

"With a growing level of trial success in horses, Therapy Cells' target is to gain FDA approval, and in short order has direct application for human tendon repair," Casey says.

"An initial valuation of $US30 million for our science and technology has been appraised.

"FDA approval for clinical use of this technology in the human, will likely increase this factor by at least 10 times."

Casey graduated as a veterinarian from Massey University in 1988, at the age of 21, and then from the University of California in 1992 with a Doctor of Philosophy in Comparative Pathology).

During his time in the United States he also completed an equine surgical internship at Hagyard-Davidson and McGee, in Lexington, Kentucky, followed by a three-year residency program in Equine Reproduction, with a minor in Equine Medicine at UC Davis.

In the early 1990s he received a post-doctoral fellowship from the Equine Research Laboratory at the University of California, which allowed him to set up with the late, world renowned, Professor Liggins at the University of Auckland, New Zealand.

 


Harley Brown and Angelli in June 2011:

 

         
         

CHEYENNE, WY- (ACCESSWIRE - August 20,2013) - Therapy Cells Inc (OTC Pink: TCEL) announces that on 13 February 2013, US patent US 11/702,895 was awarded to renowned scientist Dr Patrick Casey and Transplantation Ltd, for his transformational cell therapy, exclusively licensed to Therapy Cells Inc for use in human applications.

This revolutionary science dispenses with the traditional notion that cells cannot divide once they are fully mature. Dr Casey has shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory. These new cells can then be used for transportation back to damaged tissue in the body, to enact tissue and organ healing.

The research team headed by Dr Casey has to date treated more than 80 horses including thoroughbreds, standardbreds, polo ponies and horses at the highest level of equestrian competition.

"With a growing level of trial success in horses, Therapy Cells' target is to gain FDA approval, and in short order have human applications in human tendons," Dr Casey says. "An initial valuation of $30 million USD for our science and technology has been appraised. FDA approval for clinical use of this technology in humans, will likely increase this factor by at least 10 times." The horse is an FDA approved model species for athletic injuries.

Dr Casey is a Veterinary graduate from Massey University (BVSc, 1988), and graduate from the University of California in 1992 with a Doctor of Philosophy (PhD, Comparative Pathology). During his time in the United States he also completed an Equine Surgical Internship at Hagyard-Davidson and McGee, Lexington, Kentucky, followed by a three year residency programme in Equine Reproduction, with a minor in Equine Medicine at UC Davis. In 1992, 1993, and 1994 he received a post-doctoral fellowship from the Equine Research Laboratory at the University of California, which allowed him to set up with the late, world renowned, Professor Liggins at the University of Auckland, New Zealand.

Since 2011, Dr Casey has been chief scientific consultant to a public company in the USA - Therapy Cells Inc (TCEL on the OTC Market).

This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue, effectively by-passing the need for Stem Cell treatment.

"The financial and curative potential of this biotechnology platform is immediately obvious," states Dr Casey. "When we talk about regenerative procedures, the ability to rejuvenate tissues and organs with cultivated natural cell therapy, it's easy to understand how enormous the opportunity and the impact will be. The awarding of this US Patent for our transformational science is a significant milestone in the steps we have been taking to get our therapies to market."

Contact:

Contact: Patrick Casey

Company Headquarters:

1712 Pioneer Ave., Ste 101
Cheyenne, Wyoming
82001

Phone (USA)  001 702 666 8570

Email: info@therapycells.com

Website(s): http://www.therapycells.com/



 

Charting



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TCEL
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#18537  Sticky Note TCEL Quartely Report...Published: Aug 20,2014...Period End: Jun 30,2014 ChannelTrader 08/20/14 09:34:56 PM
#9821  Sticky Note TCEL approved patent last year http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P Multi-Bagger 07/09/14 10:03:32 PM
#18725   But the corporate headquarters is in Florida per surfkast 08/22/14 11:41:35 AM
#18724   Share Structure should be updated to 583,350,001 per surfkast 08/22/14 11:40:09 AM
#18723   I cannot afford to call internationally, I've already ljmp19 08/22/14 11:36:41 AM
#18722   Call the company and ask! surfkast 08/22/14 11:31:59 AM
#18721   That's all that matters. Once they get the FloatCleaver 08/22/14 10:50:58 AM
#18720   to be clear its 1.6 B A/S Alapis 08/22/14 10:48:52 AM
#18719   It's 1.6B shares. That's factual DD from the FloatCleaver 08/22/14 10:43:37 AM
#18718   Thanks mms again for the buying opportunity. Wayyy Tbone88 08/22/14 10:29:16 AM
#18716   Or why the email address listed is to ljmp19 08/22/14 10:00:22 AM
#18715   Hey ya 'all i have the best way catsu1 08/22/14 09:45:48 AM
#18714   Ok..But you already doing that..everyday.. Nadendla 08/22/14 09:43:46 AM
#18713   Yes.we will find out in due time..Remember TRANSPLANTATION Nadendla 08/22/14 09:35:25 AM
#18712   YES SIR - TCEL BEAST MODE THIS COMING BEAST MODE 08/22/14 09:27:01 AM
#18711   From the same filing that you are quoting.. giaiv22 08/22/14 09:25:37 AM
#18709   Ok, so these are YOUR words: ljmp19 08/22/14 08:59:21 AM
#18708   OTC stock is about making money with red jufel 08/22/14 08:54:45 AM
#18707   Will be watching closely! surfkast 08/22/14 08:49:37 AM
#18706   TCEL EXPLANATION OF RECENT BOARD ACTIVITY:http://www.investopedia.com/terms/s/st shroomalien 08/22/14 08:47:23 AM
#18705   1 Billion or 1.5 Billion authorized? surfkast 08/22/14 08:44:21 AM
#18704   Short? No, dilution! Yes! jufel 08/22/14 08:42:21 AM
#18703   keep working hard BEAST MODE 08/22/14 08:37:06 AM
#18702   Short? No, dilution! Yes! surfkast 08/22/14 08:28:52 AM
#18701   Omg....More of the same this a.m. By same ProfitSnatcher 08/22/14 08:27:49 AM
#18700   In October 2013 we had to cease trialing surfkast 08/22/14 08:21:59 AM
#18699   You missed this part From the same filing giaiv22 08/21/14 11:46:43 PM
#18698   Same here..the bulls need an excuse..or maybe they Nadendla 08/21/14 11:07:50 PM
#18697   Think we'll see a few pennies yet this Chyna9 08/21/14 11:05:22 PM
#18696   we cannot miss the terrific accumulation ..when i Nadendla 08/21/14 11:02:42 PM
#18695   Seems ready to happen anytime. Chyna9 08/21/14 10:59:02 PM
#18694   Squeeze the shorts and we will be in 004s.. Nadendla 08/21/14 10:51:03 PM
#18693   Thats a lot of hard work..presently i am Nadendla 08/21/14 10:49:33 PM
#18692   Tomorrow's range? 0010-0016?? Chyna9 08/21/14 10:48:52 PM
#18691   TCEL filings with OTC today. Conflicting reports and surfkast 08/21/14 10:46:28 PM
#18690   Also ..not answering my questions satisfactorily is the Nadendla 08/21/14 10:33:41 PM
#18689   why?.. Nadendla 08/21/14 10:32:37 PM
#18688   I know you are curious..I like your Curiosity..sometimes Nadendla 08/21/14 10:32:07 PM
#18687   Not updating the Wyoming SOS is a red flag! surfkast 08/21/14 10:31:22 PM
#18686   Isn't anyone curious why the company phone number surfkast 08/21/14 10:30:33 PM
#18685   Since you never told us your objective..should we Nadendla 08/21/14 10:27:31 PM
#18684   Thats silly ...by that we already understand that Nadendla 08/21/14 10:24:25 PM
#18683   What is the true number of authorized shares? surfkast 08/21/14 10:20:43 PM
#18682   Oh..don't bother..i think I already know..:) Nadendla 08/21/14 10:20:09 PM
#18681   I am curious..you ask soooo many questions..what is Nadendla 08/21/14 10:15:53 PM
#18680   The one that looks real..:)..ha ha..Just joking..But seriously Nadendla 08/21/14 10:15:07 PM
#18679   Which is the real filing? surfkast 08/21/14 10:11:58 PM
#18678   I know..i know..this is how pink sheet companies Nadendla 08/21/14 10:07:47 PM
#18677   NOTE 9 – SUBSEQUENT EVENTS surfkast 08/21/14 10:02:21 PM
#18676   Yes Nad...IT IS ALL GOOD!:-) MBD makingbiigdough 08/21/14 09:52:36 PM
#18675   From the same filing that you are quoting.. Nadendla 08/21/14 09:50:34 PM
#18674   ha ha..i love your sense of humour..surfcast..keep it UP..:) Nadendla 08/21/14 09:49:13 PM
PostSubject